Related Experiment Video

Updated: Jun 18, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and

Samiha Mateen1, Alpna Tyagi, Chapla Agarwal

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Denver, Aurora, Colorado 80045, USA.

Molecular Carcinogenesis
|November 13, 2009
PubMed

Insights

Silibinin, a compound found in milk thistle, effectively inhibits nonsmall cell lung cancer (NSCLC) growth by halting cell-cycle progression. This study identifies key molecular targets, offering new avenues for NSCLC treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Silibinin exhibits antineoplastic properties against various cancers.
  • Its specific effects and molecular mechanisms in nonsmall cell lung cancer (NSCLC) require further elucidation.

Purpose of the Study:

  • To evaluate the efficacy of silibinin in NSCLC.
  • To investigate the molecular mechanisms underlying silibinin's action on NSCLC cell lines.

Main Methods:

  • Three NSCLC cell lines (H1299, H460, H322) were treated with varying concentrations of silibinin.
  • Cell growth, cell-cycle progression, and levels/activity of cell-cycle regulatory molecules (cyclins, CDKs, CDKIs, Rb) were assessed.

Main Results:

  • Silibinin inhibited cell growth and induced a G1 cell-cycle arrest in a dose- and time-dependent manner.
  • It differentially modulated the protein levels of key cell-cycle regulators (CDKs, cyclins, CDKIs).
  • Silibinin reduced CDK4/2 kinase activity and Rb phosphorylation in most tested NSCLC cell lines.

Conclusions:

  • Silibinin demonstrates significant anticancer potential against diverse NSCLC subtypes.
  • The study identifies specific molecular targets, including cell-cycle regulatory proteins, for silibinin's action in NSCLC.
  • These findings highlight silibinin as a promising agent for NSCLC therapy.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...